Tapayan, Rhodalie G.
HRN: 25-81-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
CEFTRIAXONE 1G (VIAL)
09/04/2024
09/11/2024
IV
2 Grams
Once Daily
UTI Uncomplicated
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes